CHRISSELLE KIM: Open Payments
NPI 1477336998 · ENGLEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,697 in 70 payments from 25 companies in 2025. Trend: 2023 $0 · 2024 $1,665 · 2025 $1,697
Food & beverage: $1,497Education: $200
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 7 | $244 |
| Daiichi Sankyo Inc. | 10 | $232 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $157 |
| Incyte Corporation | 4 | $156 |
| Boston Scientific Corporation | 6 | $107 |
| AstraZeneca Pharmaceuticals LP | 5 | $87 |
| E.R. Squibb & Sons, L.L.C. | 5 | $85 |
| GENZYME CORPORATION | 1 | $80 |
| GlaxoSmithKline, LLC. | 4 | $73 |
| Stemline Therapeutics Inc. | 3 | $50 |
Products named: KEYTRUDA, Enhertu, Nubeqa, WATCHMAN FLX, OPDIVO, QFITLIA, TAGRISSO, JAKAFI.
Industry payments across NJ — which companies pay providers there.
